Boston Scientific Corp. BSX

NYS: BSX | ISIN: US1011371077   29/05/2026
48,31 USD (-1,63%)
(-1,63%)   29/05/2026

19 mei 2026 · FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints · Persbericht

18 mei 2026 · Boston Scientific enters into $2 billion accelerated share repurchase agreement · Persbericht

18 mei 2026 · Boston Scientific announces strategic investment in MiRus LLC · Persbericht

6 mei 2026 · Penumbra, Inc. Reports First Quarter 2026 Financial Results · Persbericht

4 mei 2026 · Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results · Persbericht

1 mei 2026 · BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

27 april 2026 · Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm · Persbericht

26 april 2026 · Data at Heart Rhythm 2026 highlight key Boston Scientific therapies · Persbericht

24 april 2026 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

22 april 2026 · Boston Scientific announces results for first quarter 2026 · Persbericht

21 april 2026 · BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

17 april 2026 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

17 april 2026 · BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

16 april 2026 · INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit · Persbericht

16 april 2026 · INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX · Persbericht

16 april 2026 · BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth: SueWallSt · Persbericht

10 april 2026 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

10 april 2026 · BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

30 maart 2026 · Boston Scientific announces conference call discussing first quarter 2026 results · Persbericht

30 maart 2026 · Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System · Persbericht

Mijn selecties